Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
01/10/1996 | CN1114588A Formulations for orally administered pharmaceutical agents |
01/10/1996 | CN1114587A EVA-based transdermal matrix system for the administration of an oestrogen and/or progestogen |
01/10/1996 | CN1114562A Medicinal cream type and foam type endogastric flotation slow-releasing agent and preparing method thereof |
01/09/1996 | US5482970 Transdermal antiandrogenic compositions and modulated process |
01/09/1996 | US5482965 Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers for physiological active agents |
01/09/1996 | US5482963 Pharmaceutical agents useful as leukotriene antagonists |
01/09/1996 | US5482945 Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements |
01/09/1996 | US5482931 Stabilized pharmaceutical peptide compositions |
01/09/1996 | US5482929 Aluminum salt of cyclodextrin sulfate |
01/09/1996 | US5482927 Injectable particles with active protein |
01/09/1996 | US5482925 Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents |
01/09/1996 | US5482719 Drug delivery systems |
01/09/1996 | US5482706 A physiologically active peptide or protein and a cytidine nucleotide |
01/09/1996 | US5482698 Detection and therapy of lesions with biotin/avidin polymer conjugates |
01/09/1996 | CA2095138C Semduramicin premix |
01/09/1996 | CA2074639C Pharmaceutical composition suitable for influencing the reticuloendothelic system and for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or accompanying diseases of tumorous origin, a process for preparing same and its use |
01/09/1996 | CA2044151C Hydrophilic polymer-silicate mineral complex material and use thereof |
01/09/1996 | CA1337899C Multi-layer granule |
01/09/1996 | CA1337898C High integrity liposomes and method of preparation and use |
01/09/1996 | CA1337897C Medicated cleansing pads |
01/04/1996 | WO1996000295A1 Targeted gene delivery system |
01/04/1996 | WO1996000294A1 Improvements in or relating to delivery of nucleic acids |
01/04/1996 | WO1996000229A1 Novel oligosaccharide derivatives, preparation method therefor and uses thereof |
01/04/1996 | WO1996000090A1 Boron-containing hormone analogs and methods of their use in imaging or killing cells having hormone receptors |
01/04/1996 | WO1996000087A2 Kit for pretargeting and novel pretargeting conjugates |
01/04/1996 | WO1996000081A1 Controlled release polypeptide compositions and methods of treating inflammatory bowel disease |
01/04/1996 | WO1996000080A1 Non-antigenic amine derived polymers and polymer conjugates |
01/04/1996 | WO1996000079A1 Graft co-polymer adducts of platinum (ii) compounds |
01/04/1996 | WO1996000066A1 Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide |
01/04/1996 | WO1996000065A1 Tacrine pharmaceutical compositions |
01/04/1996 | WO1996000060A1 Topical compositions comprising n-acetyl-l-cysteine |
01/04/1996 | WO1996000058A1 Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants |
01/04/1996 | WO1996000056A1 Method of preparing natural-oil-containing emulsions and microcapsules and its uses |
01/04/1996 | DE4423078A1 Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung Carbamazepine sustained release dosage form |
01/04/1996 | CA2193954A1 Targeted gene delivery system |
01/04/1996 | CA2193812A1 Improvements in or relating to delivery of nucleic acids |
01/04/1996 | CA2192821A1 Controlled release polypeptide compositions and methods of treating inflammatory bowel disease |
01/04/1996 | CA2191726A1 Non-antigenic amine derived polymers and polymer conjugates |
01/04/1996 | CA2187332A1 Tacrine pharmaceutical compositions |
01/04/1996 | CA2170400A1 Boron-containing hormone analogs and methods of their use in imaging or killing cells having hormone receptors |
01/03/1996 | EP0690127A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
01/03/1996 | EP0690071A2 Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase |
01/03/1996 | EP0689845A2 Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
01/03/1996 | EP0689844A1 Complexes of vinpocetine formed with cyclodextrins, process for their preparation and pharmaceutical compositions containing them |
01/03/1996 | EP0689843A1 Composition containing soluble thrombomodulins |
01/03/1996 | EP0689841A1 Powder preparation for healing damaged skin |
01/03/1996 | EP0689767A2 Skin disinfecting formulations |
01/03/1996 | EP0689604A1 Process for preparing cancer vaccines |
01/03/1996 | EP0689586A1 Vpr function and activity |
01/03/1996 | EP0689459A1 Novel agent for controlling cell activity |
01/03/1996 | EP0689458A1 Active-substance patch for releasing estradiol to the skin |
01/03/1996 | EP0689457A1 Stabilised pharmaceutical compositions and methods for preparing same |
01/03/1996 | EP0689456A1 Cosmetic compositions |
01/03/1996 | EP0689445A1 Aluminium containing pharmaceutical preparation with controlled release |
01/03/1996 | EP0689444A1 Tylosin containing sustained release veterinary compositions |
01/03/1996 | EP0689442A1 Nasal pharmaceutical composition containing a progestational agent |
01/03/1996 | EP0689441A1 Pharmaceutical composition in the form of a kit |
01/03/1996 | EP0689438A1 Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine |
01/03/1996 | EP0689434A1 Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof |
01/03/1996 | EP0689432A1 Ultramicroemulsions from spontaneously dispersible concentrates with pharmacologically effective esters of apocarotinols |
01/03/1996 | EP0689430A1 Superparamagnetic particles, process for producing the same and their use |
01/03/1996 | EP0689429A1 Cross-linked amylose as a binder/disintegrant in tablets |
01/03/1996 | EP0689428A1 Enhanced circulation effector composition and method |
01/03/1996 | EP0689427A1 Water dispersible therapeutic compounds |
01/03/1996 | EP0689425A1 Wound hydrating gel with novel preservative system and low cytotoxicity |
01/03/1996 | EP0689424A1 Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid |
01/03/1996 | EP0689422A1 Fluorocarbon emulsions with reduced pulmonary gas-trapping properties |
01/03/1996 | EP0689421A1 Reduced and controlled surface binding of biologically active molecules |
01/03/1996 | EP0689415A1 Low-viscosity cosmetic and pharmaceutical emulsions |
01/03/1996 | EP0587790B1 Non-chlorofluorocarbon aerosol formulations |
01/03/1996 | EP0525132B1 Binding of recognizing substances to liposomes |
01/03/1996 | EP0498851B1 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
01/03/1996 | EP0444158B1 Conjugated polypeptides and methods for their preparation and use |
01/03/1996 | CN1114188A Solid pharmacuetical dosage form containing flavored film coating |
01/02/1996 | US5480984 Process of preparing high solids low viscosity polysaccharides |
01/02/1996 | US5480968 Isolated polypeptide erbB-3, related to the epidermal growth factor receptor and antibody thereto |
01/02/1996 | US5480868 Sustained-release preparation |
01/02/1996 | US5480790 Water-soluble proteins modified by saccharides |
01/02/1996 | US5480653 Formulations for sustained release dressings and their use |
01/02/1996 | US5480652 Effervescent pharmaceutical composition containing ibuprofen and its method of preparation |
01/02/1996 | US5480649 Procaterol-containing preparation for application to the skin |
01/02/1996 | US5480644 Collagen for injection in anus |
12/31/1995 | CA2152982A1 Oral care products containing zinc-polyamine complex |
12/28/1995 | WO1995035321A1 Antibodies against t-cells as therapeutics |
12/28/1995 | WO1995035309A1 New thrombin inhibitors, their preparation and use |
12/28/1995 | WO1995035116A1 Hgh containing pharmaceutical compositions |
12/28/1995 | WO1995035111A2 USE OF βGalNac(1-4)βGal CONJUGATES TO TREAT CANDIDA INFECTION |
12/28/1995 | WO1995035104A1 Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl)propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients |
12/28/1995 | WO1995035097A1 Polymer microparticles for drug delivery |
12/28/1995 | WO1995035096A1 Controlled release aqueous emulsion |
12/28/1995 | WO1995035094A1 Sphingosomes for enhanced drug delivery |
12/28/1995 | WO1995035093A1 In situ gel-forming delivery vehicle for bio-affecting substances, and method of use |
12/28/1995 | WO1995035073A1 Ophthalmic delivery system |
12/28/1995 | CA2193133A1 Novel thrombin inhibitors, the preparation and use thereof |
12/28/1995 | CA2193092A1 Antibodies against t cells as therapeutics |
12/28/1995 | CA2192827A1 Use of .beta.galnac(1-4).beta.gal conjugates to treat candida infection |
12/28/1995 | CA2192708A1 In situ gel-forming delivery vehicle for bio-affecting substances, and method of use |
12/28/1995 | CA2150888A1 Powder preparation for healing damaged skin |
12/27/1995 | EP0689052A2 Insulin standard solution |
12/27/1995 | EP0688869A1 Novel osteoinductive compositions |